A
new study provides strong evidence that the experimental drug given to
two American aid workers stricken with Ebola in Africa really works and
could make a difference in the current outbreak — if more of it could be
produced.
In
the study, all 18 monkeys exposed to a lethal dose of Ebola virus
survived when given the drug, known as ZMapp, even when the treatment
was started five days after infection, when the animals were already
sick.
Moreover,
the monkeys’ symptoms, such as excessive bleeding, rashes and signs of
liver toxicity, eventually disappeared. By contrast, all three monkeys
in the control group died.
Experts
said these were the best monkey results reported to date for any Ebola
drug, raising hopes that the drug will work in people.
Experimental Drug Would Help Fight Ebola if Supply Increases, Study Finds - NYTimes.com
No comments:
Post a Comment